Frontlight ResearchEarly access
Taking peopleNo phase
Attention Deficit Hyperactivity Disorder
Key facts
- Who runs it
- Nantes University Hospital
- Where
- France3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 80 people, planned
- Started
- 11 Apr 2024
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional
- Treatments tested
- Patients suffering from the co-occurrence of ADHD and addiction(s)
- Record updated
- 17 April 2026
Who can take part
- Age
- 18 years to 99 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Patients aged over 18 years
- For whom a diagnosis of ADHD has been confirmed less than 12 weeks ago
- For whom the diagnosis of one or more addictive disorder(s) (substance use disorder or behavioral addiction) has been confirmed
- Meeting the indication for treatment with MPH according to European recommendations (Kooij et al., 2019)
- For patients who can actually benefit from MPH: who have not yet started taking MPH
- Social security affiliates
Who cannot take part
- Patients who have used psychoactive substances within 12 hours prior to their visit
- Presenting disorders of higher cognitive functions (at the discretion of the referring clinician or the investigator making the inclusion), making data collection impossible
- Presenting difficulties in reading or writing the French language making data collection impossible
- Unable to commit to being available for the 2 visits planned as part of the cohort
- Under guardianship or legal protection
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 99 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The ADA cohort aims for the systematic and standardized collection of sociodemographic, clinical and neuropsychological data, during 2 visits (inclusion and 12 months), from patients suffering from the co-occurrence of ADHD (Attention Deficit Hyperactivity Disorder) and addiction(s), in addition to the treatment as usual adapted to each situation.
The group in the trial
- Neuropsychological assessmentOther group
Determination of the neuropsychological profile
Treatment: Patients suffering from the co-occurrence of ADHD and addiction(s)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Addictions and Attention Deficit Disorder With or Without Hyperactivity
- Fit questions
- Built from NCT06232226, who can take part
- Record updated
- 17 April 2026